• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞类型影响mRNA对RNA干扰介导的沉默作用的可及性。

Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference.

作者信息

Ferguson Chantal M, Echeverria Dimas, Hassler Matthew, Ly Socheata, Khvorova Anastasia

机构信息

RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.

RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.

出版信息

Mol Ther Nucleic Acids. 2020 Sep 4;21:384-393. doi: 10.1016/j.omtn.2020.06.006. Epub 2020 Jun 12.

DOI:10.1016/j.omtn.2020.06.006
PMID:32650236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7340969/
Abstract

RNA interference (RNAi) is a potent mechanism that silences mRNA and protein expression in all cells and tissue types. RNAi is known to exert many of its functional effects in the cytoplasm, and thus, the cellular localization of target mRNA may impact observed potency. Here, we demonstrate that cell identity has a profound impact on accessibility of apolipoprotein E (ApoE) mRNA to RNAi. We show that, whereas both neuronal and glial cell lines express detectable ApoE mRNA, in neuronal cells, ApoE mRNA is not targetable by RNAi. Screening of a panel of thirty-five chemically modified small interfering RNAs (siRNAs) did not produce a single hit in a neuronal cell line, whereas up to fifteen compounds showed strong efficacy in glial cells. Further investigation of the cellular localization of ApoE mRNA demonstrates that ApoE mRNA is partially spliced and preferentially localized to the nucleus (∼80%) in neuronal cells, whereas more than 90% of ApoE mRNA is cytoplasmic in glial cells. Such an inconsistency in intracellular localization and splicing might provide an explanation for functional differences in RNAi compounds. Thus, cellular origin might have an impact on accessibility of mRNA to RNAi and should be taken into account during the screening process.

摘要

RNA干扰(RNAi)是一种强大的机制,可使所有细胞和组织类型中的mRNA和蛋白质表达沉默。已知RNAi在细胞质中发挥其许多功能作用,因此,靶mRNA的细胞定位可能会影响观察到的效力。在这里,我们证明细胞身份对载脂蛋白E(ApoE)mRNA对RNAi的可及性有深远影响。我们表明,虽然神经元和神经胶质细胞系都表达可检测到的ApoE mRNA,但在神经元细胞中,ApoE mRNA不能被RNAi靶向。对一组35种化学修饰的小干扰RNA(siRNA)进行筛选,在神经元细胞系中未产生任何有效结果,而多达15种化合物在神经胶质细胞中显示出强大的效力。对ApoE mRNA细胞定位的进一步研究表明,ApoE mRNA在神经元细胞中部分剪接并优先定位于细胞核(约80%),而在神经胶质细胞中超过90%的ApoE mRNA位于细胞质中。细胞内定位和剪接的这种不一致可能为RNAi化合物的功能差异提供解释。因此,细胞来源可能会影响mRNA对RNAi的可及性,在筛选过程中应予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/048ac3c87cd4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/8674dbf071bf/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/c51b650d0834/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/43d62a88f2a1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/048ac3c87cd4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/8674dbf071bf/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/c51b650d0834/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/43d62a88f2a1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/7340969/048ac3c87cd4/gr3.jpg

相似文献

1
Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference.细胞类型影响mRNA对RNA干扰介导的沉默作用的可及性。
Mol Ther Nucleic Acids. 2020 Sep 4;21:384-393. doi: 10.1016/j.omtn.2020.06.006. Epub 2020 Jun 12.
2
MISSION esiRNA for RNAi screening in mammalian cells.用于哺乳动物细胞RNAi筛选的MISSION esiRNA
J Vis Exp. 2010 May 12(39):2008. doi: 10.3791/2008.
3
Green fluorescent protein specified small interfering RNA-cross-linked iron oxide nanoparticles-Cy5.5绿色荧光蛋白特异性小干扰RNA交联氧化铁纳米颗粒-Cy5.5
4
Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells.由tRNA(Val)启动子控制的短发夹型双链RNA能在人细胞质中显著诱导RNA干扰介导的基因沉默。
Nucleic Acids Res. 2003 Jan 15;31(2):700-7. doi: 10.1093/nar/gkg158.
5
RNA interference in human cells is restricted to the cytoplasm.人类细胞中的RNA干扰仅限于细胞质。
RNA. 2002 Jul;8(7):855-60. doi: 10.1017/s1355838202020071.
6
Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.错配以及在小干扰RNA(siRNA)3'端引入化学修饰对培养的哺乳动物细胞中基因表达的RNA干扰(RNAi)的影响。
Antisense Nucleic Acid Drug Dev. 2002 Oct;12(5):301-9. doi: 10.1089/108729002761381285.
7
The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.基于RNA干扰的呼吸道病毒抗病毒治疗的前景、陷阱与进展
Antivir Ther. 2012;17(1 Pt B):213-25. doi: 10.3851/IMP2064. Epub 2012 Feb 3.
8
Generation of secondary small interfering RNA in cell-autonomous and non-cell autonomous RNA silencing in tobacco.烟草中细胞自主和非细胞自主RNA沉默过程中次级小干扰RNA的产生
Plant Mol Biol. 2007 Apr;63(6):803-13. doi: 10.1007/s11103-006-9124-9. Epub 2007 Jan 17.
9
TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.跨物种 RNA 干扰:细菌在 RNAi 治疗和递送方面面临的挑战的一种解决方法。
Biotechnol Genet Eng Rev. 2008;25:113-27. doi: 10.5661/bger-25-113.
10
A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.一种用于同时抑制和表达蛋白质编码序列的多重miRNA和转基因表达平台。
Mol Biosyst. 2016 Jan;12(1):295-312. doi: 10.1039/c5mb00506j.

引用本文的文献

1
Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacy.影响完全化学修饰的小干扰RNA(siRNA)功效的siRNA和信使核糖核酸(mRNA)特征的系统分析
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf479.
2
Mechanistic intracellular PK/PD modeling to inform development strategies for small interfering RNA therapeutics.用于指导小干扰RNA疗法开发策略的细胞内作用机制的药代动力学/药效学建模
Mol Ther Nucleic Acids. 2025 Mar 17;36(2):102516. doi: 10.1016/j.omtn.2025.102516. eCollection 2025 Jun 10.
3
Identification of selective and non-selective targeting active siRNAs.

本文引用的文献

1
A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system.一种二价 siRNA 化学支架,可在整个中枢神经系统中强效且持续地调节基因表达。
Nat Biotechnol. 2019 Aug;37(8):884-894. doi: 10.1038/s41587-019-0205-0. Epub 2019 Aug 2.
2
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.载脂蛋白 E 与阿尔茨海默病:发病机制与靶向治疗策略。
Nat Rev Neurol. 2019 Sep;15(9):501-518. doi: 10.1038/s41582-019-0228-7. Epub 2019 Jul 31.
3
Targeting Huntingtin Expression in Patients with Huntington's Disease.
选择性和非选择性靶向活性小干扰RNA的鉴定
Mol Ther Nucleic Acids. 2024 Jul 31;35(3):102291. doi: 10.1016/j.omtn.2024.102291. eCollection 2024 Sep 10.
4
mRNA Nuclear Clustering Leads to a Difference in Mutant Huntingtin mRNA and Protein Silencing by siRNAs .mRNA核聚集导致小干扰RNA对突变型亨廷顿蛋白mRNA和蛋白沉默的差异。
Nucleic Acid Ther. 2024 Aug;34(4):164-172. doi: 10.1089/nat.2024.0027. Epub 2024 Jul 18.
5
mRNA nuclear clustering leads to a difference in mutant huntingtin mRNA and protein silencing by siRNAs .信使核糖核酸(mRNA)的核聚集导致小干扰RNA(siRNA)对突变亨廷顿蛋白mRNA和蛋白的沉默产生差异。
bioRxiv. 2024 Apr 28:2024.04.24.590997. doi: 10.1101/2024.04.24.590997.
6
RNAi-based drug design: considerations and future directions.基于 RNAi 的药物设计:考虑因素和未来方向。
Nat Rev Drug Discov. 2024 May;23(5):341-364. doi: 10.1038/s41573-024-00912-9. Epub 2024 Apr 3.
7
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.用二价 siRNA 沉默 Apoe 可改善阿尔茨海默病的淀粉样蛋白负担并激活免疫反应途径。
Alzheimers Dement. 2024 Apr;20(4):2632-2652. doi: 10.1002/alz.13703. Epub 2024 Feb 20.
8
A combinatorial approach for achieving CNS-selective RNAi.实现中枢神经系统选择性 RNAi 的组合方法。
Nucleic Acids Res. 2024 May 22;52(9):5273-5284. doi: 10.1093/nar/gkae100.
9
Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions.挖掘基于RNA的疗法在肺部的潜力:现状与未来方向。
Front Genet. 2023 Nov 23;14:1281538. doi: 10.3389/fgene.2023.1281538. eCollection 2023.
10
Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin.JAK1 选择性 siRNA 抑制剂的合理设计用于调节皮肤自身免疫。
Nat Commun. 2023 Nov 4;14(1):7099. doi: 10.1038/s41467-023-42714-4.
靶向亨廷顿病患者的亨廷顿蛋白表达。
N Engl J Med. 2019 Jun 13;380(24):2307-2316. doi: 10.1056/NEJMoa1900907. Epub 2019 May 6.
4
Nuclear Localization of Huntingtin mRNA Is Specific to Cells of Neuronal Origin.亨廷顿 mRNA 的核定位特异性存在于神经元来源的细胞中。
Cell Rep. 2018 Sep 4;24(10):2553-2560.e5. doi: 10.1016/j.celrep.2018.07.106.
5
Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector.小分子结构矫正剂可改善人诱导多能干细胞源性神经元中毒性载脂蛋白 E4 的作用增益。
Nat Med. 2018 May;24(5):647-657. doi: 10.1038/s41591-018-0004-z. Epub 2018 Apr 9.
6
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.反义寡核苷酸和双链 RNA 的化学、机制和临床状况。
Nucleic Acids Res. 2018 Feb 28;46(4):1584-1600. doi: 10.1093/nar/gkx1239.
7
Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis.在β-淀粉样变性模型中使用反义寡核苷酸降低载脂蛋白E的年龄依赖性效应。
Neuron. 2017 Dec 6;96(5):1013-1023.e4. doi: 10.1016/j.neuron.2017.11.014.
8
Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches.肌肉生长抑制素通路在神经肌肉疾病中的下调可能解释了抗肌肉生长抑制素治疗方法的挑战。
Nat Commun. 2017 Nov 30;8(1):1859. doi: 10.1038/s41467-017-01486-4.
9
A High-throughput Assay for mRNA Silencing in Primary Cortical Neurons with Oligonucleotide Therapeutics.一种用于原代皮质神经元中mRNA沉默的寡核苷酸治疗药物的高通量检测方法。
Bio Protoc. 2017 Aug 20;7(16). doi: 10.21769/BioProtoc.2501.
10
Targeted Intron Retention and Excision for Rapid Gene Regulation in Response to Neuronal Activity.靶向内含子保留和切除以快速响应神经元活动的基因调控。
Neuron. 2016 Dec 21;92(6):1266-1278. doi: 10.1016/j.neuron.2016.11.032.